[HTML][HTML] Prospective of 68Ga-radiopharmaceutical development

I Velikyan - Theranostics, 2014 - ncbi.nlm.nih.gov
Abstract Positron Emission Tomography (PET) experienced accelerated development and
has become an established method for medical research and clinical routine diagnostics on …

The present and future of medical radionuclide production

SM Qaim - Radiochimica Acta, 2012 - degruyter.com
Medical radionuclide production technology is well established. Both reactors and
cyclotrons are utilized for production; the positron emitters, however, are produced …

Past, present and future of 68Ge/68Ga generators

F Rösch - Applied Radiation and Isotopes, 2013 - Elsevier
68Ga represents one of the very early radionuclides applied to positron emission
tomography (PET) imaging at a time when even the wording PET itself was not established …

Intrinsically germanium‐69‐labeled iron oxide nanoparticles: synthesis and in‐vivo dual‐modality PET/MR imaging

R Chakravarty, HF Valdovinos, F Chen… - Advanced …, 2014 - Wiley Online Library
Inspired by these, we hypothesized that using a suitable water soluble metal oxide as a
platform, 69Ge-labeled metal oxides could be synthesized simply by mixing metal oxide with …

The current status of the production and supply of gallium-68

K Kumar - Cancer biotherapy & radiopharmaceuticals, 2020 - liebertpub.com
Gallium-68 (68Ga) is an important radionuclide due to its successful use in the clinic.
Currently, 68Ga is produced and supplied by using germanium-68/Gallium-68 (68Ge/68Ga) …

[HTML][HTML] Radionuclide generators: the prospect of availing PET radiotracers to meet current clinical needs and future research demands

A Dash, R Chakravarty - American journal of nuclear medicine and …, 2019 - ncbi.nlm.nih.gov
Targeted molecular imaging with positron emission tomography (PET) constitutes a
successful technique for detecting and diagnosing disease conditions promptly and …

[HTML][HTML] 68Ga-DOTA and analogs: Current status and future perspectives

K Kilian - Reports of Practical Oncology & Radiotherapy, 2014 - Elsevier
The construction of the 68 Ge/68 Ga generator has increased application of
radiopharmaceuticals labeled with this isotope in medicine. 68 Ga-PET is widely employed …

Maturation of a key resource–the germanium-68/gallium-68 generator: development and new insights

F Roesch - Current radiopharmaceuticals, 2012 - ingentaconnect.com
68Ge/68Ga radionuclide generators have been investigated for almost fifty years, since the
cyclotronindependent availability of positron emitting 68Ga via the 68Ge/68Ga system had …

Feasibility and availability of 68Ga-labelled peptides

C Decristoforo, RD Pickett, A Verbruggen - European journal of nuclear …, 2012 - Springer
Abstract 68 Ga has attracted tremendous interest as a radionuclide for PET based on its
suitable half-life of 68 min, high positron emission yield and ready availability from 68 Ge/68 …

Gallium-68: chemistry and radiolabeled peptides exploring different oncogenic pathways

C Morgat, E Hindié, AK Mishra, M Allard… - Cancer Biotherapy …, 2013 - liebertpub.com
Early and specific tumor detection and also therapy selection and response evaluation are
some challenges of personalized medicine. This calls for high sensitive and specific …